MassGeneral Clinical Trial to Evaluate 
Study Drug Safety & How It Works in the Body

with the Possibility of Improved Cognitive Capacities in People with Down Syndrome 

Dr. Brian Skotko and his research team from the MassGeneral Hospital Down Syndrome Program are starting another study drug trial.  

 

In this clinical trial, an investigational medicine, not yet approved for sale by the FDA, will be studied in people with Down syndrome who meet eligibility criteria.  This study drug is hoped to improve the cognitive capacities in some people with Down syndrome.

 

Up until now, opportunities for people with Down syndrome to participate in research have been scant, for a variety of reasons.  For the first time, study drug trials are now available to people with Down syndrome.  Enhancing the well-being of all people with Down syndrome remains the greatest aim of all of the research opportunities that we offer through the Mass General Hospital Down Syndrome Program.

 

There are a limited number of spots for this clinical trial, and eligible patients are screened in the order in which they contact us. 

 

This study is being funded by Elan, the developer of the drug in the upcoming study. The upcoming clinical trial will evaluate the safety of the study drug and how it works in the body.  The study will take place over 10 weeks and will include 5 clinic visits.

 

To see if your family member is eligible to take part in the study, you can review the question on MGH's Down Syndrome Research page here

 

If you would like your family member to participate in this study, or if you have further questions, please contact Mary Ellen McDonough, RN, Senior Clinical research Coordinator in the MassGeneral Hospital Down Syndrome program by calling 617-643-5571 or by emailing her at [email protected] 

 

Note: The Massachusetts Down Syndrome Congress (MDSC) is informing you of this research on behalf of MassGeneral Hospital Down Syndrome Program. The MDSC is dedicated to ensuring that all members have information about and access to the latest research opportunities; we review each research proposal for content, ethics, and feasibility before forwarding information to you. At no time does the MDSC sell or share your MDSC member contact information with researchers. The MDSC will not be informed by the researchers about who agrees to participate in this research. Your agreement to participate or not to participate will in no way impact any services, support, or resources that you receive from the MDSC. To read about this and other Research Opportunities, go here

Find us on: 

Like us on FacebookView our videos on YouTubeFollow us on Twitter

 

Promoting Acceptance & Inclusion

Massachusetts Down Syndrome Congress Mission

We work to ensure individuals with Down syndrome in Massachusetts are valued, included, and given the opportunities to pursue fulfilling lives by providing information, networking opportunities, and advocacy for people with Down syndrome and their families, educators, health care professionals, and the community-at-large.

 

www.mdsc.org